DE60042057D1 - Bukkales verabreichungssystem für proteinhaltige medikamente - Google Patents

Bukkales verabreichungssystem für proteinhaltige medikamente

Info

Publication number
DE60042057D1
DE60042057D1 DE60042057T DE60042057T DE60042057D1 DE 60042057 D1 DE60042057 D1 DE 60042057D1 DE 60042057 T DE60042057 T DE 60042057T DE 60042057 T DE60042057 T DE 60042057T DE 60042057 D1 DE60042057 D1 DE 60042057D1
Authority
DE
Germany
Prior art keywords
bukkales
protein
administration system
formulation
containing medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60042057T
Other languages
English (en)
Inventor
David D Mundschenk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESPERANZA PEPTIDE Ltd
Original Assignee
ESPERANZA PEPTIDE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESPERANZA PEPTIDE Ltd filed Critical ESPERANZA PEPTIDE Ltd
Application granted granted Critical
Publication of DE60042057D1 publication Critical patent/DE60042057D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60042057T 1999-01-29 2000-01-28 Bukkales verabreichungssystem für proteinhaltige medikamente Expired - Fee Related DE60042057D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24045599A 1999-01-29 1999-01-29
PCT/US2000/002210 WO2000044393A2 (en) 1999-01-29 2000-01-28 Buccal delivery system for proteinaceous medicaments

Publications (1)

Publication Number Publication Date
DE60042057D1 true DE60042057D1 (de) 2009-06-04

Family

ID=22906597

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042057T Expired - Fee Related DE60042057D1 (de) 1999-01-29 2000-01-28 Bukkales verabreichungssystem für proteinhaltige medikamente

Country Status (7)

Country Link
US (1) US20070014735A1 (de)
EP (1) EP1146890B1 (de)
AT (1) ATE429240T1 (de)
AU (1) AU2862600A (de)
CA (1) CA2361262A1 (de)
DE (1) DE60042057D1 (de)
WO (1) WO2000044393A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0501037B8 (pt) * 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
AT506216B1 (de) * 2008-02-13 2009-07-15 Peter Dr Hernuss Zusammensetzung zur aufnahme über mukoses gewebe
US20100291160A1 (en) * 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
EP0327756B1 (de) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel
EP0550031B1 (de) * 1991-12-31 1996-05-08 Hoechst Aktiengesellschaft Medizinische Aerosolformulierung
EP0912726A4 (de) * 1996-05-10 2001-07-18 Phylomed Corp Verfahren zur oxidation von disulfid-bindungen durch gebrauch von ozon

Also Published As

Publication number Publication date
EP1146890B1 (de) 2009-04-22
ATE429240T1 (de) 2009-05-15
WO2000044393A2 (en) 2000-08-03
WO2000044393A3 (en) 2000-12-14
CA2361262A1 (en) 2000-08-03
US20070014735A1 (en) 2007-01-18
AU2862600A (en) 2000-08-18
EP1146890A2 (de) 2001-10-24

Similar Documents

Publication Publication Date Title
CA2376978A1 (en) Compositions and methods for treatment of sexual dysfunction
WO2003079972A3 (en) Active agent delivery systems and methods for protecting and administering active agents
CA2329005A1 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
HUP0103318A2 (hu) Eljárás hatóanyagok bevitelére tüdőn keresztül
EP0528312A3 (de) Zyklische Peptide und ihre Verwendung
CA2214323A1 (en) Compounds and compositions for delivering active agents
ES2155124T3 (es) Composiciones farmaceuticas liquidas a base de hormonas tiroideas.
WO2002017918A3 (en) Sustained release formulations for growth hormone secretagogues
SE8007763L (sv) Sett att framstella en polypeptid
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
NO20052041L (no) Administrasjonsform for farmasoytisk aktive peptider med vedvarende frigivelse og fremgangsmate for fremstilling av denne
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
CA2287534A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
DE60042057D1 (de) Bukkales verabreichungssystem für proteinhaltige medikamente
ES2167189A1 (es) Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
ES2131482B1 (es) Formulacion acuosa de bambuterol.
NZ510446A (en) Gastrointestinal delivery of LH-RH peptide analogues
EP1593384A3 (de) Verbindungen zur Behandlung von sexuellen Funktionsstörungen
GB9910375D0 (en) Vaccine composition
UA83996C2 (ru) Фармацевтическая гелевая композиция пептидов, способ ее получения, набор для ее получения и ее применение
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
HUP9800235A2 (hu) Eljárás bőrfertőzések kezelésére és megelőzésére alkalmas külsőleges gyógyászati készítmények előállítására
TH26711A (th) " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต "

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee